Observational Study - Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Tubular Carcinoma
N/A
30 Years
85 Years
30 Years
85 Years
Open (Enrolling)
Both
Pancreatic Tubular Adenocarcinoma
Both
Pancreatic Tubular Adenocarcinoma
Trial Information
Observational Study - Influence of Gemcitabine Treatment on Immunological and Serological Profile in Patients With Pancreatic Tubular Carcinoma
Inclusion Criteria:
- ECOG performance status 0-2 at the time of inclusion
- Following R0 or R1 pancreatic tubular adenocarcinoma resection
Exclusion Criteria:
- Pregnancy
- Serious comorbidity
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Authority:
Slovenia: Ethics Committee
Study ID:
Gemcitabine1
NCT ID:
NCT00947102
Start Date:
February 2009
Completion Date:
December 2011
Related Keywords:
- Pancreatic Tubular Adenocarcinoma
- pancreatic tubular adenocarcinoma
- gemcitabine
- gene expression
- immunological status
- serological status
- pancreatic tubular adenocarcinoma adjuvant setting
- Adenocarcinoma
- Adenocarcinoma, Mucinous
Name | Location |
|---|
